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1. Introduction 
Human salivary amylase exists in multiple forms, 
some of which are glycosylated [ 1,2] . The glycosylat- 
ed part appears to be constant with different donors 
and with various origin: parotid and submandibular 
glands [3] . 
In this paper we investigate the nature of two peaks 
with a-amylase activity, which were obtained during 
the purification of the main components of human 
parotid saliva: cr-amylase, proline-rich glycoproteins 
and proteins (PRP). Previous investigations had shown 
that this kind of molecules consisted of about 64% of 
prolyproline II helical structure, 29% of p-turns and 
7% of unordered structure [4,5] . That these peculair 
proteins may modify or protect the cr-amylase 
activity is discussed. 
2. Materials and methods 
2.1. Isolation of ff-amylase 
Human parotid saliva was collected from a single 
donor as previously described [4] . cu-Amylase was 
purified by gel-filtration chromatography. 
2.1.1. Chromatography of parotid saliva on Sephadex 
G-200 
300 mg of parotid saliva were applied to a column 
of Sephadex G-200 (4.5 X 70 cm). The column was 
equilibrated with 0.1 M sodium phosphate 0.2 M 
NaCl buffer, pH 8.0 and 5 ml fractions were collected. 
The effluent was monitored at 278 and 230 nm. 
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Carbohydrate containing components were located by 
means of orcinol-sulphuric acid reagent [6]. Each 
fraction from Sephadex G-200 were studied for 
chemical composition or further purified. 
2.1.2. Fractionation of cu-amylase on Sephadex G-100 
Fraction 4 (Sephadex G-200) was subsequently 
loaded into a column of Sephadex G-100 
(2.5 X 100 cm). The column was equilibrated with 
0.1 M sodium phosphate, 0.2 M NaCl buffer, pH 8.0. 
The elution profile was determined by 230 and 278 
nm ultra violet absorption, orcinol-sulphuric acid 
reaction and amylase activity measurements. 
2.2. Amylase assay 
Amylase’activity was measured by the method of 
Bernfeld [7]. One unit of amylase was defined as the 
amount of enzyme which hydrolyzed 5 mg of starch 
per 15 min at 37°C. 
2.3. Chemical composition 
Amino acid analysis was performed with a 
Technicon amino acid analyzer after 5.6 N HCl 
hydrolysis for 24 h at 1OO’C [6]. Carbohydrate 
composition was determined by quantitative gas-liquid 
chromatography [8]. 
2.4. Circular dichroism measurements 
The circular dichroism was measured with a Jobit- 
Yvon dichrograph R. J. Mark III in 0.01 cm pathlength 
at an absorbance less than 1.5. The samples (FIIa, 
FIIb, FIIc) were dissolved in 10 mM sodium phosphate 
buffer and 0.1 M NaF. The pH was 6.45. The protein 
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concentration of the solutions was determined by the 
Lowry method [9] and was always about 1 mg/ml. 
The ellipticity [O] was expressed as mean residual 
molar ellipticity [O] in degrees. cm* .decimole-’ . The 
mean residue weight was 100 for FIIc, 105 for FIIb 
and 109 for FIIa. The ellipticity curves were 
constructed from at least five spectra. Even if the 
protein is glycosylated the CD spectrum is charact- 
eristic of the protein moiety; indeed, we have seen in 
a previous paper [5] that the contribution of the 
glycan chains to the ellipticity in the 180-250 nm 
domain is always less than 2% and therefore could be 
neglected. 
3. Results 
3.1. Purification of par0 tid wamylase 
Sephadex G-200 chromatography (fig. 1 a) resulted 
Fig.1. (a) Elution diagram of human parotid saliva on 
Sephadex G-200 column. (b) gel filtration chromatography 
of G-200 F, on Sephadex G-100. 
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in five fractions numbered in order of elution from 
the column. Fraction 1 was a minor peak. Fractions 
2 and 3 corresponded to proline-rich glycoproteins 
as previously demonstrated [S] . Fraction 4 exhibited 
cu-amylase activity and was further purified on 
Sephadex G-100 column (tig. 1 b). Two peaks were 
separated. The second FII appeared to be heterogene- 
ous: three fractions FIIa, FIIb, FIIc were pooled 
according to their a-amylase activity and to their 
relative absorption at 278 and 230 nm. 
3.2. Chemical analysis 
Amino acid and carbohydrate analysis were 
performed in fractions FIIa, FIIb and FIIc (Sephadex 
G-l 00) and in fraction F2 (Sephadex G-200) (see 
table 1). 
The two fractions FIIa and FIIb which exhibited 
cr-amylase activity had different amino acid composi- 
tions. FIIa composition was very close to that of 
o-amylase preparations obtained by other workers 
[ 1 ,101 , FIIc was rich in three amino acid residues, 
proline, glycine and glutamic acid and/or glutamine). 
Table 1 
Amino acid composition of o-amylase fractions and 
proline-rich glycoprotein or protein of human parotid saliva 
_ 
Amino acids A B C D 
_____ -__ 
Aspartic acid 6.75 13.36 10.62 9.50 
Threonine 1.81 4.76 3.16 0.90 
Serine 7.89 8.19 8.02 6.48 
Glutamic acid 15.60 7.i2 13.03 22.43 
Proline 28.78 6.52 17.11 26.55 
Glycine 22.58 13.56 16.44 18.37 
Alanine 2.13 6.13 4.39 2.77 
Half-cystine 0 1.42 0.87 0 
Valine 1.14 6.13 4.16 2.77 
Methionine 0 1.67 0.61 0 
Isoleucine 0.59 3.93 2.54 0.82 
leucine 1.51 5.21 3.71 2.83 
Tyrosine 0.48 4.18 2.66 0.53 
Phenylalanine 0.50 4.54 3.05 0.83 
Lysine 4.77 5.00 4.48 3.59 
Histidine 1.14 2.71 1.50 0.41 
Arginine 4.14 5.54 3.61 1.17 
(A) F, Sephadex G-200: Proline-rich glycoprotein 
(B) FIIa Sephadex G-100: o-amylase 
(C) FIIb Sephadex G-100: or-amylase-PRP 
(D) FIIc Sephadex G-100: PRP 
(Values expressed as residues/100 amino acid residues) 
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Fig.2. Experimental dichroic spectra of FIIa (---) FIIb 
(---) and FIIc (-_) fractions (Sephadex G-100). 
This fraction was devoided of carbohydrate. Thus, 
this PRP was very similar to the glycoprotein 
characterized by chromatography on Sephadex 
G-200 (Fa). 
Amino-acid composition of FIIb was reminding 
of PRP but was found to contain a-amylase activity 
and thus might be considered as a complex between 
cu-amylase and PRP. FIIa and FIIb contained less than 
2% carbohydrate. 
3.3. Enzymatic activity 
cr-Amylase activity of the PR glycoprotein 
(Fa Sephadex G-200) and fractions FIIa, FIIb, FIIc 
(Sephadex G-100) was measured. The enzymatic 
activity was related to dry weight powder. The results 
are presented in table 2. 
Table 2 
o-Amylase activity according to the method of Bernfeld 
F, Scphadex G-200 
FIIa Sephadex G-100 
FIIb Sephadex GlOO 
FIIc Sephadex G-1 00 
363 U/mg 
8722 U/mg 
15023 lJ/mg 
1612 U/mg 
Results expressed as units per mg of dry weight powder. 
Proline-rich proteins (FIIc) were added to 
cu-amylase preparation (FIIa). The amylase/PRP ratios 
(w/w) were l/l; l/2; l/4; l/8; l/16; l/32. As shown 
fig.3, the presence of PRP increased cw-amylase activity. 
3.4. Circular dichroism study 
Non-glycosylated PRP (FIIc Sephadex G-100), 
fractions FIIa and FIIb were studied and the 
corresponding CD spectra between 180 and 250 nm 
are shown in fig.2. The shape of the fraction FIIc 
spectrum reminds of the one obtained for PRP [5]. 
Indeed a strong negative band centered at 203 nm 
with an ellipticity [O] max: 31.103 is observed. 
The FIIa CD spectrum is very different from that 
of FIIc. More especially, it presents two negative 
bands at 227 and 208 nm and a positive band at 190 
nm with ellipticities of -5900, -5600 and 3000 
respectively. It does not correspond to one definite 
Fig.3. Effect of PRP on o-amylase activity. 
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structure or a combination of the usual three structures 
found in proteins (i.e. o-helical, P-sheets and unordered 
structures). Since this fraction FIIa exhibits a-amylase 
activity and presents an amino acid composition 
similar to a-amylase, the spectrum should correpond 
to amylase. The CD band centered at 227 nm does 
not exactly correspond to the position of the n + n* 
transition of the o-helical form. We do think that 
such a band is due to a weak proportion of the helical 
form in the a-amylase. Moreover, the solution presented 
a light turbidity when we recorded the spectrum. 
Urry [lo] showed that such a turbidity induced a 
disortion of the CD spectrum, more especially a shift 
to high values of wavelength was observed. Therefore, 
in our case the band at 227 nm could correspond to 
the n -+ n* transition generally observed at 222 nm. 
Finally, the FIIb CD spectrum is intermediate 
between the spectra of FIIa and FIIc. A weak band is 
observed at 227 nm and a more important at 203 nm. 
This is in excellent agreement with the enzymatic 
activity (Sephadex G-100) and chemical studies. 
4. Discussion 
When setting our results three comments had to be 
made :
(1) cu-amylase in human parotid saliva could be 
separated in two forms and it should be noticed that 
if one of the two (FIIa) might be considered according 
to amino acid analysis as a pure amylase preparation, 
the second one (FIIb) appeared with the same criteria 
and with circular dichroism spectra as a complex of 
a-amylase and PRP. The chemical and physical results 
led US to consider that a-amylase was present in low 
quantity in FIIb fraction. 
(2) The significative difference of amylase activity 
between FIIa and FIIb may be related to interactions 
between cu-amylase and proline-rich proteins. PRP 
addition to o-amylase increase the specific activity 
of this enzyme (fig.3). 
(3) The biological role of the proline-rich proteins 
and glycoproteins had not yet been defined. An 
hypothetical function of these PRP might be also to 
protect the enzyme during the secretion process of 
the parotid gland. As reported by Amsterdam, the PRP 
are present as structural units of the zymogen granule 
membranes [ 111. 
Acknowledgements 
We thank Miss D. Debacker, Miss D. Van Der Loo 
and Mrs M. P. Hildebrand for their excellent technical 
assistance. This research was supported by grants 
from INSERM (n” 74-5-030-2) and from DGRST 
(n” 75-7-0915). 
References 
[1] Kauffman, D. L., Zager, N. I., Cohen, E. and Keller, 
P. J. (1970) Arch. Biochem. Biophys. 137, 325-339. 
[Z] Keller, P. J., Kauffman, D. L., Ailan, B. J. and Williams, 
B. L. (1971) Biochemistry 10,4867-4874. 
[3] Kauffman, D. L., Watanabe, S., Evans, J. E. and Keller, 
P. J. (1973) Arch. Oral. Biol. 18, 1105-l 112. 
[4] Degand, P., Boersma, A., Roussel, P., Richet, C. and 
Biserte, G. (1975) FEBS Lett. 54, 189-192. 
[5] Aubert, J. P., Boersma, A., Loucheux-Lefebvre, M. H., 
Degand, P. and Biserte, G. (1975) FEBS Lett. 56, 
263-267. 
[6] Degand, P., Roussel, P., Lamblin, G. and Havez, R. 
(1973) Biochim. Biophys. Acta 320, 318-330. 
[7] Bernfeld, P. (1955) Meth. Enzymol. 1, 149-158. 
[8] Reinhold, V. N. (1972) Meth. Enzymol. 25, 244-249. 
[9] Lowry, 0. H., Rosenbrough, N. J., Farr, A. L., Randall, 
R. J. (1951) J. Biol. Chem. 193, 265-275. 
[lo] Urry, D. W. (1969) in: Spectroscopic Approaches to 
Biomolecular Conformation (Urry, D. W., ed.) 
American Medical Association (Chicago). 
[ll] Amsterdam, A., Schramm, M., Ohad, I., Salmon, Y. 
and Selinger, Z. (1971) J. Cell. Biol. 50, 187-200. 
140 
